Skip to content

Clinical Studies

As a healthcare professional, you need a higher level of proof than your patient. Here we discuss how InterX® is different, certifications, and clinical studies.

How InterX® Therapy is Unique

InterX® has US, EU, and Australian patents on our technology. Here are some key words within these patents which discuss our uniqueness:

"Neuro Stimulation": This means stimulation of nerves in cases where the signal to the brain has been interrupted. Another definition "helping the nervous system to remember."
"Non-invasive", "transcutaneous": This means that the electrical signal to the brain travels along the exterior of the skin, which can tingle sometimes. Most other medical devices send their electrical current through the body, which can be painful. A higher level of electrical stimulation is possible when current travels across the skin.
"Self-directing": InterX®devices tell you the location of the best spot on the skin area to treat.
"Multiple devices and accessories". Treatment with multiple devices and accessories accelerates the healing process.

 

Clinical Studies

A number of InterX® clinical studies have been done in the U.S., Great Britain, Italy, Russia, and Australia. All measured pain reduction. Several also measured reduction in pain medication and length of hospitalization required.Shown below in detail are those studies which meet a higher level of research quality. Controlled, Randomized, 60 or more patients, Published.

cov200h

Noninvasive Interactive Neurostimulation Therapy for the Treatment of Low-Grade Lateral Ankle Sprain Improves the Short-Term Recovery and Return to Sport: A Prospective, Randomized Controlled Trial

Country Italy
Clinical Evidence 1

InterX® has been used by athletic trainers around the world to shorten time of injury recovery.


Improvements Measured

YES | Reduction in Pain
YES | Reduction in Medication

cov200h

Use of Noninvasive Interactive Neurostimulation to Improve Short-Term Recovery in Patients with Surgically Repaired Bimalleolar Ankle Fractures: A Prospective, Randomized Clinical Trial

Country Russia
Clinical Evidence 1


Improvements Measured

YES | Reduction in Pain
YES | Reduction in Medication
YES | Increased Range of Motion
YES | Reduced Edema

cov200h

Treatment of Chronic Plantar Fasciitis with Noninvasive Interactive Neurostimulation: A Prospective Randomized Controlled Study

Country Italy
Clinical Evidence 2

Tiziano Marovino (DPT,MPH, DAIPM), writing in the October 2020 issue of Practical Pain Management (link below) is in the process of evaluating the InterX 5002 device, and describes his efforts to recruit patients for a trial group with both the InterX device and a sham device to control for placebo.

He states: “it is important to note that it was next to impossible to recruit patients who had experienced InterX prior to our receiving the sham unit into the comparative trial because they simply said their sessions were too valuable and did not want to risk not getting the actual treatment. As a result we had to recruit patients who were unfamiliar with the device for our comparative trial…”


Improvements Measured

YES | Reduction in Pain
YES | Reduction in Medication
YES | Patient Satisfaction

clinicaldoc3

 

Non-invasive Interactive Neurostimulation (InterX®) Reduces Acute Pain in Patients Following Total Knee Replacement Surgery: A Randomized, Controlled Trial

Country UK
61 patient study
Clinical Evidence Level Not Listed

Results: The effects varied slightly between male and female patients. Males took more medication than females in both the active and the sham groups. However, there was a reduction of medication in the active groups compared to sham. While still maintaining a low pain score comparable with sham patients taking more medication, male patients in the active group reduced their medication intake by 34% and female patients reduced their medication intake by 16%. Patients in the active group were discharged on average 1.2 days earlier than the sham group. We conclude that this technology warrants further investigation and there is use for InterX® in the management of pain after total hip arthroplasty. The financial implications of reduced rehabilitation time are of significant value as healthcare costs come under greater scrutiny and pressures.


Improvements Measured

YES | Reduction in Pain
YES | Reduction in Medication
YES | Increased Range of Motion
YES | Reduced Edema

Bone-and-joint-journal

 

Non-invasive interactive neurostimulation in the post operative recovery of patients with a trochanteric fracture of the femur

Country Russia
61 patient study
Clinical Evidence Level Not Listed

This 60 patient study showed improvements in pain, walking, sleep, enjoyment of life, mood, and overall assessment of outcome by an orthopedic surgeon.


Improvements Measured

YES | Reduction in Pain
YES | Reduction in Medication
YES | Patient Satisfaction

Transform Pain Relief With InterX Therapy While Growing Your Practice


Become an InterX Affiliate